Phase I evaluation of telatinib, a VEGF receptor tyrosine...

Annals of Oncology 2011 / 11 Vol. 22; Iss. 11

Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors

Langenberg, M. H. G., Witteveen, P. O., Roodhart, J., Lolkema, M. P., Verheul, H. M. W., Mergui-Roelvink, M., Brendel, E., Kratzschmar, J., Loembe, B., Nol-Boekel, A., Christensen, O., Schellens, J. H
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdq767
Date:
November, 2011
File:
PDF, 350 KB
english, 2011
Conversion to is in progress
Conversion to is failed